Our results demonstrate that urinary titin levels increase in response to muscle damage and catabolism in four different mouse models: acute injury by cardiotoxin, disuse (immobilization), systemic inflammation (lipopolysaccharide-induced sepsis), and metabolic disorder (Streptozotocin-induced diabetes). Here, TTN is linked to metabolic disease.